4RE1 | Crystal structure of human TEAD1 and disulfide-engineered YAP | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Xu, Z., Zhou, Z. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.20 | ||||||||||||
ligand | CL | enzyme |
| ||||||||||||
Primary reference | Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides., Zhou Z, Hu T, Xu Z, Lin Z, Zhang Z, Feng T, Zhu L, Rong Y, Shen H, Luk JM, Zhang X, Qin N, FASEB J. 2015 Feb;29(2):724-32. doi: 10.1096/fj.14-262980. Epub 2014 Nov 10. PMID:25384421 |
Data retrieval |
View 4RE1 in 3D |
Visual 3D analysis of 4RE1 |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4RE1 |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |